哌啶-1,4-二乙醇 | 50325-75-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 哌啶-1,4-二乙醇
• 中文别名: 铑,[(1,2,3,4-h)-1,2,3,4,5,6-六甲基苯][(1,2,3,4,5-h)-1,2,3,4,5-五甲基-2,4-环戊二烯-1-基]-
• 英文名称: Piperidine-1,4-diethanol
• 英文别名: 2-[1-(2-hydroxyethyl)piperidin-4-yl]ethanol
• CAS: 50325-75-2
• 化学式: C₉H₁₉NO₂
• 分子量: 173.25
• InChiKey: FYUUJRJXBDQPCJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  43.7
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

文献信息

• [EN] CHEMICAL COMPOUNDS<br/>[FR] DERIVES DE QUINAZOLINE POUR LE TRAITEMENT DU CANCER
  申请人：ASTRAZENECA AB

  公开号：WO2004094410A1

  公开（公告）日：2004-11-04

  Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to processes for their preparation, as well as pharmaceutical compositions containing them as active ingredient.

  公式（I）的喹唑啉衍生物；用于治疗癌症等增殖性疾病，并用于制备用于治疗增殖性疾病的药物，以及它们的制备方法，以及含有它们作为活性成分的药物组合物。
• N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF
  申请人：Yokotani Junichi

  公开号：US20110275797A1

  公开（公告）日：2011-11-10

  An N-acyl anthranilic acid derivative represented by general formula (1) or a salt thereof is useful for prevention or treatment of diseases associated with excessive production of collagen. (In the formula, R 1 represents a carboxyl group or the like; R 2 represents a hydrogen atom or the like; R 3 represents an optionally substituted aryl group or the like; X 1 represents a carbonyl group; X 2 represents a bonding hand; X 3 represents a bonding hand; X 4 represents a bonding hand or the like; and A represents an optionally substituted phenyl group or the like.)

  通用公式（1）表示的N-酰基蒽酸衍生物或其盐对预防或治疗与胶原蛋白过度产生相关的疾病具有用处。（在该公式中，R1代表羧基或类似物；R2代表氢原子或类似物；R3代表可选择取代的芳基或类似物；X1代表羰基；X2代表连接手；X3代表连接手；X4代表连接手或类似物；A代表可选择取代的苯基或类似物。）
• COATING COMPOSITION
  申请人：Houlihan Francis

  公开号：US20100119972A1

  公开（公告）日：2010-05-13

  Developable bottom antireflective coating compositions are provided.

  提供可开发底部防反射涂层组合物。
• Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
  申请人：——

  公开号：US20040096506A1

  公开（公告）日：2004-05-20

  Bioerodible poly(ortho esters) useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents from dioxane-based di(ketene acetals). Block copolymers contain these bioerodible poly(ortho esters). These block copolymers have both hydrophilic and hydrophobic blocks. They form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; and they also form bioerodible matrices for the sustained release of active agents.

  生物可降解的聚酯类（ortho esters）可用作骨科植入物或从二噁烷基二（酮酸酯）中提供药物、化妆品和农业剂量的持续释放载体。这些生物可降解的聚酯类是由含有这些聚酯类的嵌段共聚物组成的。这些嵌段共聚物具有亲水和疏水的嵌段。它们在水溶液中形成胶束，适用于封装或溶解疏水或不溶于水的材料；它们还形成生物可降解的基质，用于持续释放活性成分。
• Substituted quinazoline derivatives as inhibitors of aurora kinases
  申请人：Jung Henri Frederic

  公开号：US20050070561A1

  公开（公告）日：2005-03-31

  The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharamceutical compositions containing them and their use in therapy.

  该发明提供了化学式（I）的喹唑啉衍生物：在制备用于抑制极化丝激酶的药物时，以及新的喹唑啉衍生物，它们的制备过程，包含它们的药物组合物以及它们在治疗中的使用。